Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours

C. Twelves; K. Hoekman; A. Bouwman; J.B. Vermorken; A. Anthoney; J. Smyth; C. van Kesteren; J.H. Beijnen; J. Uiters; J. Wanders; J. Gomez; C. Guzman; J.M. Jimeno; A.R. Hanauske

Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours

C. Twelves, K. Hoekman, A. Bouwman, J.B. Vermorken, A. Anthoney, J. Smyth, C. van Kesteren, J.H. Beijnen, J. Uiters, J. Wanders, J. Gomez, C. Guzman, J.M. Jimeno, A.R. Hanauske

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1842-1851
Number of pages	10
Journal	European Journal of Cancer
Volume	39
Publication status	Published - 2003

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Farmacie(FARM)

Cite this

Twelves, C., Hoekman, K., Bouwman, A., Vermorken, J. B., Anthoney, A., Smyth, J., van Kesteren, C., Beijnen, J. H., Uiters, J., Wanders, J., Gomez, J., Guzman, C., Jimeno, J. M., & Hanauske, A. R. (2003). Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours. European Journal of Cancer, 39, 1842-1851.

@article{1ba64133a5234faeba6a8c04733b1dc1,

title = "Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Farmacie(FARM)",

author = "C. Twelves and K. Hoekman and A. Bouwman and J.B. Vermorken and A. Anthoney and J. Smyth and {van Kesteren}, C. and J.H. Beijnen and J. Uiters and J. Wanders and J. Gomez and C. Guzman and J.M. Jimeno and A.R. Hanauske",

year = "2003",

language = "Undefined/Unknown",

volume = "39",

pages = "1842--1851",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

Twelves, C, Hoekman, K, Bouwman, A, Vermorken, JB, Anthoney, A, Smyth, J, van Kesteren, C, Beijnen, JH, Uiters, J, Wanders, J, Gomez, J, Guzman, C, Jimeno, JM & Hanauske, AR 2003, 'Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours', European Journal of Cancer, vol. 39, pp. 1842-1851.

TY - JOUR

T1 - Phase I and pharmacokinetic study of Yondelis (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours

AU - Twelves, C.

AU - Hoekman, K.

AU - Bouwman, A.

AU - Vermorken, J.B.

AU - Anthoney, A.

AU - Smyth, J.

AU - van Kesteren, C.

AU - Beijnen, J.H.

AU - Uiters, J.

AU - Wanders, J.

AU - Gomez, J.

AU - Guzman, C.

AU - Jimeno, J.M.

AU - Hanauske, A.R.

PY - 2003

Y1 - 2003

KW - Farmacie/Biofarmaceutische wetenschappen (FARM)

KW - Farmacie(FARM)

M3 - Article

SN - 0959-8049

VL - 39

SP - 1842

EP - 1851

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -